T12	Exp 228 230	We
T13	Exp 374 378	that
T14	Exp 341 353	the activity
T15	Exp 387 404	the IL-2 promoter
T16	Exp 631 656	their corresponding sites
T17	Exp 543 554	the binding
T18	Exp 660 682	the IL-2 gene promoter
T19	Exp 847 849	we
T20	Exp 789 816	the structural requirements
T21	Exp 974 982	its AP-1
T22	Exp 946 970	the intact IL-2 promoter
T23	Exp 1023 1040	the IL-2 promoter
T24	Exp 1045 1053	the AP-1
T25	Exp 1063 1072	the NF-AT
T26	Exp 1120 1137	the IL-2 promoter
T27	Exp 1142 1151	the NF-AT
T28	Exp 1161 1169	the AP-1
T29	Exp 1212 1216	that
T30	Exp 1190 1203	These results
T31	Exp 1355 1357	We
T32	Exp 1366 1370	that
T33	Exp 1462 1480	the primary target
R4	Coref Anaphora:T13 Antecedent:T34
R5	Coref Anaphora:T16 Antecedent:T35
R6	Coref Anaphora:T21 Antecedent:T22
T1	Protein 45 58	interleukin 2
T2	Protein 60 64	IL-2
T3	Protein 163 167	IL-2
T4	Protein 297 301	IL-2
T5	Protein 391 395	IL-2
T6	Protein 664 668	IL-2
T7	Protein 821 825	IL-2
T8	Protein 957 961	IL-2
T9	Protein 1027 1031	IL-2
T10	Protein 1124 1128	IL-2
T11	Protein 1267 1271	IL-2
T34	Exp 357 373	nuclear proteins
T35	Exp 406 422	Nuclear extracts
